Idarubicin hydrochloride

Aurantio-obtusin.

Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The ª-defensins are distinguished from the ß-defensins by the pairing of their three

Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The ª-defensins are distinguished from the ß-defensins by the pairing of their three

ApplicationDL-Arabinose is used in physicochemical studies to measure properties such as dielectric relaxation. It may be used in chiral separation of sugars. DL-Arabinose, is a building block of polysaccharide (CCPa-1) from fungus Coprinus comatus

ApplicationDL-Arabinose is used in physicochemical studies to measure properties such as dielectric relaxation. It may be used in chiral separation of sugars. DL-Arabinose, is a building block of polysaccharide (CCPa-1) from fungus Coprinus comatus

An antibiotic supplement recommended for selective isolation of E. coli O157:H7. Storage and Shelf Life Store at 2-8°C. Use before the expiry date on the label.

Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.An apoptosis inducer.

Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.An apoptosis inducer.

Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.An apoptosis inducer.

Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL.An apoptosis inducer.

Application Idarubicin is an anthracycline antibiotic that is an anti-leukemia agent with higher DNA binding capacity and greater cytotoxicity than daunorubicin. Biochem/physiol Actions Topoisomerase II inhibitor Features and Benefits This compound

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the